• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD. BIOMIMICS 3D VASCULAR STENT SYSTEM; BIOMIMICS3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD. BIOMIMICS 3D VASCULAR STENT SYSTEM; BIOMIMICS3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 142122-03
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Claudication (2550); Patient Problem/Medical Problem (2688)
Event Date 01/21/2019
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of claudication and occlusion/restenosis are listed in the biomimics 3d instructions for use and are known patient effects of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available a follow-up report will be submitted.
 
Event Description
This is the same case as mdr id 3011632150-2019-00041.The patient was treated as part of the (b)(6) study on (b)(6) 2015.At index procedure ((b)(6) 2015), the patient presented with a de-novo occlusion located in the distal superficial femoral artery (sfa) of the left leg.Two biomimics 3d stents were implanted.On (b)(6) 2019 restenosis of the left distal sfa was reported.Patient had office visit (b)(6) 2019 where he was given an option for conservative medical management with exercise therapy and repeat duplex doppler study, but patient elected to undergo angiography intervention directly.The patient has recovered.The device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD.
blk 11 galway technology park
parkmore
galway, ireland H91VE 0H
EI  H91VE0H
Manufacturer (Section G)
VERYAN MEDICAL
blk 11 galway technology park
parkmore
galway, galway H91 V E0H
EI   H91 VE0H
Manufacturer Contact
william bachinsky
harrisburg hospital
111 south front st.
7177310101
MDR Report Key8394457
MDR Text Key137949688
Report Number3011632150-2019-00042
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 03/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2017
Device Catalogue Number142122-03
Device Lot Number287381
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/06/2019
Initial Date FDA Received03/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
ASPIRIN 81 MG; CLOPIDOGREL 75MG
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient Weight83
-
-